134 related articles for article (PubMed ID: 7918081)
1. Long-term follow-up of aplastic anaemia.
Narayanan MN; Geary CG; Freemont AJ; Kendra JR
Br J Haematol; 1994 Apr; 86(4):837-43. PubMed ID: 7918081
[TBL] [Abstract][Full Text] [Related]
2. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience.
Li Y; Li X; Ge M; Shi J; Qian L; Zheng Y; Wang J
Ann Hematol; 2011 May; 90(5):529-37. PubMed ID: 21207031
[TBL] [Abstract][Full Text] [Related]
4. Persistent growth impairment of bone marrow stroma after antilymphocyte globulin treatment for severe aplastic anaemia and its association with relapse.
Nissen C; Wodnar-Filipowicz A; Slanicka Krieger MS; Slanicka Gratwohl A; Tichelli A; Speck B
Eur J Haematol; 1995 Oct; 55(4):255-61. PubMed ID: 7589344
[TBL] [Abstract][Full Text] [Related]
5. Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.
Sun L; Babushok DV
Blood; 2020 Jul; 136(1):36-49. PubMed ID: 32430502
[TBL] [Abstract][Full Text] [Related]
6. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
Maciejewski JP; Risitano A; Sloand EM; Nunez O; Young NS
Blood; 2002 May; 99(9):3129-35. PubMed ID: 11964274
[TBL] [Abstract][Full Text] [Related]
7. Analysis of abnormal clones by the fluorescent aerolysin method in paroxysmal nocturnal haemoglobinuria and other marrow disorders.
Agarwal R; Chapple P; Brown M; Szer J; Juneja S
Int J Lab Hematol; 2015 Feb; 37(1):14-21. PubMed ID: 24702736
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
[TBL] [Abstract][Full Text] [Related]
9. Progressive telomere shortening in aplastic anemia.
Ball SE; Gibson FM; Rizzo S; Tooze JA; Marsh JC; Gordon-Smith EC
Blood; 1998 May; 91(10):3582-92. PubMed ID: 9572992
[TBL] [Abstract][Full Text] [Related]
10. Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia.
Ishihara S; Nakakuma H; Kawaguchi T; Nagakura S; Horikawa K; Hidaka M; Asou N; Mitsuya H
Int J Hematol; 2000 Aug; 72(2):206-9. PubMed ID: 11039670
[TBL] [Abstract][Full Text] [Related]
11. Evolution of clonal cytogenetic abnormalities in aplastic anemia.
Maciejewski JP; Selleri C
Leuk Lymphoma; 2004 Mar; 45(3):433-40. PubMed ID: 15160903
[TBL] [Abstract][Full Text] [Related]
12. Myelodysplasia following aplastic anaemia-paroxysmal nocturnal haemoglobinuria syndrome after treatment with immunosuppression and G-CSF: evidence for the emergence of a separate clone.
Jin JY; Tooze JA; Marsh JC; Matthey F; Gordon-Smith EC
Br J Haematol; 1996 Sep; 94(3):510-2. PubMed ID: 8790151
[TBL] [Abstract][Full Text] [Related]
13. [A study of hypoplastic myelodysplastic syndrome].
Sato Y; Mituhashi S; Otani K; Kamoshita M; Hasegawa Y; Ninomiya H; Nagasawa T; Abe T
Rinsho Ketsueki; 1993 Nov; 34(11):1431-7. PubMed ID: 8254904
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT).
de Planque MM; Bacigalupo A; Würsch A; Hows JM; Devergie A; Frickhofen N; Brand A; Nissen C
Br J Haematol; 1989 Sep; 73(1):121-6. PubMed ID: 2803967
[TBL] [Abstract][Full Text] [Related]
15. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
16. Long-term (5 to 20 years) Evolution of nongrafted aplastic anemias. The Cooperative Group for the Study of Aplastic and Refractory Anemias.
Najean Y; Haguenauer O
Blood; 1990 Dec; 76(11):2222-8. PubMed ID: 2257296
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria.
Araten DJ; Swirsky D; Karadimitris A; Notaro R; Nafa K; Bessler M; Thaler HT; Castro-Malaspina H; Childs BH; Boulad F; Weiss M; Anagnostopoulos N; Kutlar A; Savage DG; Maziarz RT; Jhanwar S; Luzzatto L
Br J Haematol; 2001 Nov; 115(2):360-8. PubMed ID: 11703336
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome.
Horikawa K; Nakakuma H; Kawaguchi T; Iwamoto N; Nagakura S; Kagimoto T; Takatsuki K
Blood; 1997 Oct; 90(7):2716-22. PubMed ID: 9326238
[TBL] [Abstract][Full Text] [Related]
19. Late clonal diseases of treated aplastic anemia.
Socié G; Rosenfeld S; Frickhofen N; Gluckman E; Tichelli A
Semin Hematol; 2000 Jan; 37(1):91-101. PubMed ID: 10676914
[TBL] [Abstract][Full Text] [Related]
20. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
